Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime - Archive ouverte HAL Access content directly
Journal Articles Biomolecules Year : 2020

Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime

(1, 2) , (1, 2) , (1, 2) , (1, 2) , (1) , (1, 2) , (1) , (1) , (3, 4) , (3, 4) , (5) , (6) , (6) , (6) , (6) , (7) , (7) , (7) , (1)
1
2
3
4
5
6
7

Abstract

Background: Human exposure to organophosphorus compounds employed as pesticides or as chemical warfare agents induces deleterious effects due to cholinesterase inhibition. One therapeutic approach is the reactivation of inhibited acetylcholinesterase by oximes. While currently available oximes are unable to reach the central nervous system to reactivate cholinesterases or to display a wide spectrum of action against the variety of organophosphorus compounds, we aim to identify new reactivators without such drawbacks. (2) Methods: This study gathers an exhaustive work to assess in vitro and in vivo efficacy, and toxicity of a hybrid tetrahydroacridine pyridinaldoxime reactivator, KM297, compared to pralidoxime. (3) Results: Blood-brain barrier crossing assay carried out on a human in vitro model established that KM297 has an endothelial permeability coefficient twice that of pralidoxime. It also presents higher cytotoxicity, particularly on bone marrow-derived cells. Its strong cholinesterase inhibition potency seems to be correlated to its low protective efficacy in mice exposed to paraoxon. Ventilatory monitoring of KM297-treated mice by double-chamber plethysmography shows toxic effects at the selected therapeutic dose. This breathing assessment could help define the No Observed Adverse Effect Level (NOAEL) dose of new oximes which would have a maximum therapeutic effect without any toxic side effects.
Fichier principal
Vignette du fichier
Calas et al., 2020.pdf (4.32 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03127255 , version 1 (19-07-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

André-Guilhem Calas, Anne-Sophie Hanak, Nina Jaffré, Aurélie Nervo, José Dias, et al.. Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime. Biomolecules, 2020, 10 (6), pp.858. ⟨10.3390/biom10060858⟩. ⟨hal-03127255⟩
32 View
39 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More